Results 261 to 270 of about 464,232 (352)
Balancing Health, Sustainability, and Food Assurance in Fast-Food Choice: A Discrete Choice Experiment in Taiwan. [PDF]
Ma CC, Chang HP.
europepmc +1 more source
Spatial scales, stakeholders and the valuation of ecosystem services
L. Hein +3 more
semanticscholar +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Valuation of Medical Innovation in Orphan Diseases with a Focus on Small Investors and Limited Diversifiable Risks. [PDF]
Nuijten M, Gelder PV.
europepmc +1 more source
Corporate Governance and Firm Valuation
Lawrence D. Brown, M. Caylor
semanticscholar +1 more source
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
Robust Competitive Ratio for Deterministic Monopoly Pricing. [PDF]
Eck TSGV, Kleer P, Leeuwaarden JSHV.
europepmc +1 more source
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park +6 more
wiley +1 more source

